60 likes | 202 Views
Managing depression in people with long term conditions. Chris Dickens Professor of Psychological Medicine Peninsula College of Medicine and Dentistry. Long term condition – LTCs . LTCs such as coronary heart disease and diabetes affect 17.5 millions throughout the UK
E N D
Managing depression in people with long term conditions Chris Dickens Professor of Psychological Medicine Peninsula College of Medicine and Dentistry
Long term condition – LTCs • LTCs such as coronary heart disease and diabetes affect 17.5 millions throughout the UK • almost 1 in 3 of the general population • Account for • about 60% of all deaths • Account for about 70% of all healthcare expenditure • Reducing the health burden and costs attributable to LTCs is a priority for economies of many developed countries.
Depression in people with LTCs • Depression affects about 5% of the UK population • Prevalence much higher in people with LTCs • 10 to 50% have clinically significant depression • Another 10-50% have other common mental disorders and sub-syndromal distress • Depression is associated with worse medical outcomes • Double mortality and morbidity • 50% increase in use of urgent healthcare • Depression treatments are required for LTC patients • To improve emotional quality of life • Possibly to improve medical outcomes
Depression in LTCs • Depression is under-detected and under-treated in people with LTCs • Only about 20% as likely to receive appropriate depression treatment compared to depressed physically healthy individuals • My research is about • understanding the causes and effects of depression people with LTCs • Devising novel ways of treating depression in people with LTCs
Findings to date • The natural history of depression in people with LTCs is complex • Depression can predate LTC, be caused by general psychosocial difficulties and contribute to the onset of the LTC • Depression can arise in the context of the LTC in response stresses specific to the LTCs • Depression is associated worse medical outcome • risks associated vary depending on the timing of the onset of depression. • Adverse emotional reactions to LTC are be predicted by a persons concerns and understanding about their illness, but also by the amount they worry about their illness. • Treatment of depression is advocated, though barriers to treatment exist at the level of the patient, the healthcare practitioner, the healthcare system • Existing treatments are not very effective in LTCs • SMD for CBT in CHD = 0.28, similar for DM and COPD
Future directions • Treatment for depression is advisable in people with LTCS but: • How can we develop psychological therapies that address the specific needs of people with LTCs – that improve depression but are acceptable to patients? • How can such treatments be delivered in a way that overcomes barriers? • Can such treatments be delivered by non-specialists in primary care? • Can such treatments should be effective across different LTCs? • Does treating depression improve health behaviours? • Does treating depression improve medical outcomes? • If you are interested in doing research into any of these areas, please come and speak to me…….. • Thankyou